Avatrombopag

Cat. No.REF-A90041
CAS. No.570406-98-3
Molecular FormulaC29H34Cl2N6O3S2
Molecular Weight649.65 g/mol
Inventory StatusPlease enquire.

描述

Cat. No.REF-A90041
CAS. No.570406-98-3
Molecular FormulaC29H34Cl2N6O3S2
Molecular Weight649.65 g/mol
Synonyms1-(3-chloro-5-((4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)carbamoyl)pyridin-2-yl)piperidine-4-carboxylic acid
AppearanceWhite solid
Storage TemperatureN/A
ApplicationsAvatrombopag is a medication that used for certain conditions that lead to thrombocytopenia (low platelets) such as thrombocytopenia associated with chronic liver disease in adults who are to undergo a planned medical or dental procedure.It was the third thrombopoietin receptor agonist approved for the treatment of immune thrombocytopenia and the first approved to treat periprocedural thrombocytopenia in patients with chronic liver disease (thereby providing an alternative to blood transfusions for these patients). Avatrombopag was approved for medical use in the United States in 2018, and in the European Union in 2019.

Buy Avatrombopag from Toref at best competitive price. We provide best quality Avatrombopag. Every compound produced by Toref is accompanied by Certificate of Analysis. If you need different pack size / quantity, please contact us or email us at order@toref-standards.com.

评价

目前还没有评价

成为第一个“Avatrombopag” 的评价者

您的电子邮箱地址不会被公开。 必填项已用 * 标注

Online Inquiry